BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3908048)

  • 1. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 2. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G; Domschke S; Domschke W
    Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
    Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
    [No Abstract]   [Full Text] [Related]  

  • 4. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
    Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H
    Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen.
    Ernst CS; Atkinson B; Chianese D; Peters J; Perry M; Herlyn M; Koprowski H
    Appl Pathol; 1986; 4(3):115-24. PubMed ID: 2885017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.
    Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS
    Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
    Yao CZ; Zeng XJ; Wang SZ
    Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antigens associated with cancer of the pancreas].
    Burtin P
    Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical analysis of physicochemical properties of target antigens with anti-tumor monoclonal antibodies].
    Liu MP
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):6-8. PubMed ID: 1396049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
    Allum WH; Macdonald F; Fielding JW
    Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ; Hornung A; Anderer FA; Kieninger G
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CO 17-1A and related monoclonal antibodies: their production and characterization.
    Herlyn M; Steplewski Z; Herlyn D; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S3-10. PubMed ID: 3744383
    [No Abstract]   [Full Text] [Related]  

  • 16. [New data on experimental tumor immunology].
    Schneeweiss U; Gummel H
    Z Exp Chir; 1972; 5(2):66-80. PubMed ID: 4680973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.